(Q37899200)

25 August 2017

1 reference

title

B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy (English)

1 reference

25 August 2017

Seok Jin Kim

1

1 reference

PubMed ID

21740304

25 August 2017

Jong Ho Won

series ordinal

2

1 reference

25 August 2017

6 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

53

1 reference

25 August 2017

1

1 reference

25 August 2017

19-25

1 reference

Chronic graft-versus-host disease: clinical manifestation and therapy

25 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Current challenges in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Rituximab for steroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

B cell receptor and BAFF receptor signaling regulation of B cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Signalling crosstalk in B cells: managing worth and need

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

The BLyS family: toward a molecular understanding of B cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Control of B lymphocyte apoptosis by the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

The role of B cells in the pathogenesis of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.603448

10.3109/10428194.2011.603448

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21740304